Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Taylor Swift Movie Sparks Debate About Etiquette at Theaters
Taylor Swift's concert tour has dominated the box office in recent days and it's also the top-grossing concert film of all time here in the U.S. But a conversation on social media raised questions about movie etiquette and videos shared show film audiences singing, shining their phone flashlights and dancing in the aisles.
Stocks Fall Amid Renewed Fears Over Rate Hikes
Stocks fell at the open Tuesday as the 10-year Treasury yield spiked following retail sales data and bank earnings, raising concerns over more rate hikes. Investors are also keeping an eye on tensions in the Middle East and its potential effect on global markets.
Load More